Trial Outcomes & Findings for Cognitive Behavioral Therapy for Adherence in Patients With Type 2 Diabetes (NCT NCT04214600)

NCT ID: NCT04214600

Last Updated: 2020-11-27

Results Overview

Assess the effect of the CBT combined with diabetes education versus control receiving diabetes education alone on glycemic measures of patients with T2D and depression

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

100 participants

Primary outcome timeframe

Baseline and 3 months

Results posted on

2020-11-27

Participant Flow

Participant milestones

Participant milestones
Measure
Cognitive Behavioral Therapy
This group will receive four CBT sessions twice a month for two months Cognitive Behavioral Therapy (CBT): Patients in the CBT intervention group will receive four educational sessions for 30-45 minutes on one to one basis every two weeks during patients' regular follow up visits. The visits will be scheduled depending on the patient's availability. The sessions will be delivered by a trained physician. The sessions will include: Session 1: Dealing with thoughts of sadness and depression Session 2: Dealing with thoughts of anxiety and stress Session 3: Dealing with anger Session 4: Enhancement of coping and problem-solving skills
Control
This group will be scheduled the same number of visits as a follow up for diabetes
Overall Study
STARTED
50
50
Overall Study
COMPLETED
41
36
Overall Study
NOT COMPLETED
9
14

Reasons for withdrawal

Reasons for withdrawal
Measure
Cognitive Behavioral Therapy
This group will receive four CBT sessions twice a month for two months Cognitive Behavioral Therapy (CBT): Patients in the CBT intervention group will receive four educational sessions for 30-45 minutes on one to one basis every two weeks during patients' regular follow up visits. The visits will be scheduled depending on the patient's availability. The sessions will be delivered by a trained physician. The sessions will include: Session 1: Dealing with thoughts of sadness and depression Session 2: Dealing with thoughts of anxiety and stress Session 3: Dealing with anger Session 4: Enhancement of coping and problem-solving skills
Control
This group will be scheduled the same number of visits as a follow up for diabetes
Overall Study
Lost to Follow-up
9
14

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Cognitive Behavioral Therapy
n=50 Participants
This group will receive four CBT sessions twice a month for two months Cognitive Behavioral Therapy (CBT): Patients in the CBT intervention group will receive four educational sessions for 30-45 minutes on one to one basis every two weeks during patients' regular follow up visits. The visits will be scheduled depending on the patient's availability. The sessions will be delivered by a trained physician and will include: Session 1: Dealing with thoughts of sadness and depression Session 2: Dealing with thoughts of anxiety and stress Session 3: Dealing with anger Session 4: Enhancement of coping and problem-solving skills
Control
n=50 Participants
This group will be scheduled the same number of visits as a follow up for diabetes.
Total
n=100 Participants
Total of all reporting groups
Age, Customized
Age interval · 35-44
5 Participants
n=50 Participants
12 Participants
n=50 Participants
17 Participants
n=100 Participants
Age, Customized
Age interval · 45-54
19 Participants
n=50 Participants
18 Participants
n=50 Participants
37 Participants
n=100 Participants
Age, Customized
Age interval · 45-64
11 Participants
n=50 Participants
6 Participants
n=50 Participants
17 Participants
n=100 Participants
Age, Customized
Age interval · ≥65
15 Participants
n=50 Participants
14 Participants
n=50 Participants
29 Participants
n=100 Participants
Sex: Female, Male
Female
16 Participants
n=50 Participants
15 Participants
n=50 Participants
31 Participants
n=100 Participants
Sex: Female, Male
Male
34 Participants
n=50 Participants
35 Participants
n=50 Participants
69 Participants
n=100 Participants
Race and Ethnicity Not Collected
0 Participants
Race and Ethnicity were not collected from any participant.

PRIMARY outcome

Timeframe: Baseline and 3 months

Population: Of the 100 patients that met the inclusion criteria and completed the baseline assessment, only 77 patients completed the post-intervention assessment.

Assess the effect of the CBT combined with diabetes education versus control receiving diabetes education alone on glycemic measures of patients with T2D and depression

Outcome measures

Outcome measures
Measure
CBT Group
n=41 Participants
Participants received four Cognitive Behavioral Therapy sessions and diabetes education
Control Group
n=36 Participants
Participants received diabetes education only
Change of Glycated Hemoglobin A1c (Hb A1c) After the Cognitive Behavioral Therapy Sessions
7.70 percent
Standard Error 0.23
8.42 percent
Standard Error 0.25

SECONDARY outcome

Timeframe: baseline and 3 months

Population: Of the 100 patients that met the inclusion criteria and completed the baseline assessment, only 77 patients completed the post intervention assessment.

Assess the effect of the CBT combined with diabetes education versus control receiving diabetes education alone on depressive symptoms of patients with T2D and depression (Beck's Depression Index scores range between 1-40 where high scores mean worsening outcome and low scores mean improving outcome)

Outcome measures

Outcome measures
Measure
CBT Group
n=41 Participants
Participants received four Cognitive Behavioral Therapy sessions and diabetes education
Control Group
n=36 Participants
Participants received diabetes education only
Change of Depression Score on Beck's Depression Index
12.25 score on a scale
Standard Error 1.09
16.49 score on a scale
Standard Error 1.16

Adverse Events

CBT Group

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Control Group

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Nadine Mansour

Cairo University

Phone: (+2)01001482455- 01001465719

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place